Cargando…

Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers

Ovarian cancers encompass a group of neoplasms originating from germinal tissues and exhibiting distinct clinical, pathological, and molecular features. Among these, epithelial ovarian cancers (EOCs) are the most prevalent, comprising five distinct tumor histotypes. Notably, high-grade serous ovaria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azzalini, Eros, Stanta, Giorgio, Canzonieri, Vincenzo, Bonin, Serena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10606847/ https://www.ncbi.nlm.nih.gov/pubmed/37894756 http://dx.doi.org/10.3390/ijms242015077

Ejemplares similares

AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
por: Azzalini, Eros, et al.
Publicado: (2022)

Reliability of miRNA Analysis from Fixed and Paraffin-Embedded Tissues
por: Azzalini, Eros, et al.
Publicado: (2019)

Overview on Clinical Relevance of Intra-Tumor Heterogeneity
por: Stanta, Giorgio, et al.
Publicado: (2018)

A Novel HPLC-Based Method to Investigate on RNA after Fixation
por: Fattorini, Paolo, et al.
Publicado: (2020)

The Tumor Microenvironment of High Grade Serous Ovarian Cancer
por: Stack, M. Sharon, et al.
Publicado: (2018)

Targeting the Microenvironment in High Grade Serous Ovarian Cancer
por: Nwani, Nkechiyere G., et al.
Publicado: (2018)

Cell Origins of High-Grade Serous Ovarian Cancer
por: Kim, Jaeyeon, et al.
Publicado: (2018)

High-grade serous ovarian cancer: the clone wars
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2017)

Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression
por: Mota, Alba, et al.
Publicado: (2015)

Nanomechanical Characterization of Ovarian Cancer Cell Lines as a Marker of Response to 2c Treatment
por: Tierno, Domenico, et al.
Publicado: (2023)

Principles of dormancy evident in high-grade serous ovarian cancer
por: Shepherd, Trevor G., et al.
Publicado: (2022)

Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
por: Schwarz, Roland F., et al.
Publicado: (2015)

Targeted Mutational Analysis of Circulating Tumor DNA to Decipher Temporal Heterogeneity of High-Grade Serous Ovarian Cancer
por: Paracchini, Lara, et al.
Publicado: (2022)

Clinical Implications of DNA Repair Defects in High-Grade Serous Ovarian Carcinomas
por: Milanesio, Michela Camilla, et al.
Publicado: (2020)

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
por: Cooke, Susanna L, et al.
Publicado: (2010)

Single‐cell transcriptomes reveal heterogeneity of high‐grade serous ovarian carcinoma
por: Hao, Qian, et al.
Publicado: (2021)

Molecular Management of High-Grade Serous Ovarian Carcinoma
por: Punzón-Jiménez, Paula, et al.
Publicado: (2022)

The Potential of Targeting Ribosome Biogenesis in High-Grade Serous Ovarian Cancer
por: Yan, Shunfei, et al.
Publicado: (2017)

High-throughput approaches for precision medicine in high-grade serous ovarian cancer
por: Govindarajan, Meinusha, et al.
Publicado: (2020)

Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS)
por: Garziera, Marica, et al.
Publicado: (2018)

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
por: Morgan, Robert D., et al.
Publicado: (2018)

Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics
por: Handley, Katelyn F., et al.
Publicado: (2022)

Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC)
por: Garziera, Marica, et al.
Publicado: (2019)

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
por: Tone, Alicia A, et al.
Publicado: (2014)

High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
por: Lisio, Michael-Antony, et al.
Publicado: (2019)

Exploiting the Prevalence of Homologous Recombination Deficiencies in High-Grade Serous Ovarian Cancer
por: Bouberhan, Sara, et al.
Publicado: (2020)

Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer
por: Matthews, Bayley G., et al.
Publicado: (2021)

High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation
por: Bourgeois, Danielle L., et al.
Publicado: (2015)

Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis
por: Yang, Bin, et al.
Publicado: (2022)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress
por: Cesaratto, Laura, et al.
Publicado: (2016)

BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress
por: Cesaratto, Laura, et al.
Publicado: (2016)

Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens
por: Hunt, Allison L., et al.
Publicado: (2021)

Dualistic classification of high grade serous ovarian carcinoma has its root in spatial heterogeneity
por: Sun, Tingting, et al.
Publicado: (2022)

Advances in Tumor Screening, Imaging, and Avatar Technologies for High-Grade Serous Ovarian Cancer
por: Ohman, Anders W., et al.
Publicado: (2014)

Role of the immune system in the peritoneal tumor spread of high grade serous ovarian cancer
por: Auer, Katharina, et al.
Publicado: (2016)

The peritoneal tumour microenvironment of high-grade serous ovarian cancer
por: Leinster, D Andrew, et al.
Publicado: (2012)

Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer
por: Coan, Michela, et al.
Publicado: (2018)

DNA methylation-based profiling reveals distinct clusters with survival heterogeneity in high-grade serous ovarian cancer
por: Wang, Jieyu, et al.
Publicado: (2021)

Digital Pathology-based Study of Cell- and Tissue-level Morphologic Features in Serous Borderline Ovarian Tumor and High-grade Serous Ovarian Cancer
por: Jiang, Jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3qbsah3g9s24dnia4fhmcj4vk9